Breaking News:, Inc. Unveils First CBD Skincare Line on Alibaba’s Largest Online Retail Platform, Tmall, Inc. (OTCQB: CIIX) (“CIIX” or “the Company”), a leading online financial information provider and seller of industrial hemp CBD products for the global Chinese community, today announced that its subsidiary, CBD Biotechnology Co. Ltd., has entered into Alibaba Group’s Tmall (NYSE: BABA), China’s largest e-commerce marketplace for global and domestic brands and retailers.

This move significantly expands the Company’s footprint and reach of its full line of CBD skincare products to include Alibaba’s 500 million registered customers on Taobao and Tmall just in time to welcome the Double 11, also known as Singles’ Day, and Double 12 Shopping Festivals. These two national events occur between October and December and have historically yielded China’s highest volume of sales for online merchandise, adopted by online retailers and driven by Alibaba’s Taobao and Tmall. Singles’ Day is a national occasion for single adults to celebrate and socialize, which is highlighted by shopping festivals.

Warren Wang, CEO of, commented, “CBD Biotechnology Co. Ltd. is not only one of the first companies to produce and sell CBD skincare products in China, but now it is the first CBD skincare company to enter Tmall. We now have significantly extended our sales channel and through our dedication in educating our audience on the benefits of our product, believe that we are on the path to strengthening our brand influence for the massive cosmetics industry within China and the global Chinese community. From October 15 through the end of December 2018, our company will invest 2.5 million RMB in online marketing and advertising for all of our CBD skincare product lines. The total single day volume of transactions during the Double Eleven Shopping Festival in 2017 reached 168.2 billion. We are thrilled to be participating in the Double 11 and Double 12 Shopping Festivals this year.”

Alibaba’s Tmall global e-commerce marketplace provides a variety of products and high-quality brands on its e-commerce online platform. According to the agreement, Tmall will feature CBD Biotechnology’s skincare line for its 500 million registered customers, providing a new opportunity for CIIX to expand the reach of its products into the Chinese market.

Xiangyang Hui, CEO of CBD Biotechnology Co. Ltd., adds, “Of the hundreds of thousands of companies that apply for authorization to be included on Tmall, few are approved, making this one of the most sought after e-commerce platforms. This is an amazing opportunity and huge accomplishment to successfully open our own store. We will be advertising on well-known online platforms and apps like Today’s Headline, Tik Tok,, Watermelon Video, Iqiyi and Baidu Information Flow. We estimate that from October 2018 to September 2019, the total sales of CBD skincare products will have the opportunity to reach 12 million RMB.”

For further information, please visit CBD Biotechnology Co. Ltd.’s Tmall store at

Sponsored Content Release. Click for Full Disclosure

  1. Daniel Mirkin 6 months ago

    cbd topicals are amazing, who knew absorption through the skin from cbd would hold benefits

  2. Larry Dubois 6 months ago

    hemp-based skincare can ease severe acne, chronic pain and eczema in weeks

Leave a Comment

  • Sponsored Content Release, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, creates 100% unique original content. also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

    Please Note: is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on  (the ‘Site’) is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content),, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. receives fees for producing and presenting high quality and sophisticated content on along with other financial news PR media services. does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For Inc. financial news dissemination and PR services, expects to be compensated three thousand dollars by the company. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. will always disclose any compensation in securities or cash payments for financial news PR advertising. has signed a two-year agreement with Inc. for one hundred thousand restricted common shares for continued financial news dissemination and PR services. does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security., members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: .